204 related articles for article (PubMed ID: 15229776)
21. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
[TBL] [Abstract][Full Text] [Related]
22. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
Tabone M; Vigano L; Laudi C; Ferrero A; Pellerito R; Capussotti L
Hepatology; 2005 Jun; 41(6):1433; author reply 1433-4. PubMed ID: 15834934
[No Abstract] [Full Text] [Related]
24. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
Ikeda K; Saitoh S; Kumada H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
[TBL] [Abstract][Full Text] [Related]
25. A comparative randomized trial of intermittent intrahepatic arterial carboplatin- versus doxorubicin-lipiodol emulsion in advanced hepatocellular carcinoma (stage IV).
Homma H; Mezawa S; Doi T; Miyanishi K; Takada K; Kukitsu T; Oku T; Masuko E; Nojiri S; Niitsu Y
Hepatogastroenterology; 2004; 51(58):1135-9. PubMed ID: 15239261
[TBL] [Abstract][Full Text] [Related]
26. Treatment of unresectable hepatocellular carcinoma with radiolabelled lipiodol.
Kanhere HA; Leopardi LN; Fischer L; Kitchener MI; Maddern GJ
ANZ J Surg; 2008 May; 78(5):371-6. PubMed ID: 18380736
[TBL] [Abstract][Full Text] [Related]
27. Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol).
Kobayashi H; Nakajo M; Yano T; Shimabukuro K; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1176-8. PubMed ID: 3005962
[No Abstract] [Full Text] [Related]
28. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
[TBL] [Abstract][Full Text] [Related]
29. [Ethanol mixtured with lipiodol regional injection therapy].
Kokubu S; Murakami M; Takada M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():558-68. PubMed ID: 11762012
[No Abstract] [Full Text] [Related]
30. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
Doffoël M; Bonnetain F; Bouché O; Vetter D; Abergel A; Fratté S; Grangé JD; Stremsdoerfer N; Blanchi A; Bronowicki JP; Caroli-Bosc FX; Causse X; Masskouri F; Rougier P; Bedenne L;
Eur J Cancer; 2008 Mar; 44(4):528-38. PubMed ID: 18242076
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
Launois B; Maddern G
Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
[No Abstract] [Full Text] [Related]
32. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
Rai R; Rai S
Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
[No Abstract] [Full Text] [Related]
33. [Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol)].
Kajiya Y; Nakajo M; Kobayashi H; Oyama T; Shinohara S
Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):815-21. PubMed ID: 2849622
[No Abstract] [Full Text] [Related]
34. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
[TBL] [Abstract][Full Text] [Related]
35. Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative (131)I-lipiodol therapy.
Brans B; Lambert B; De Beule E; De Winter F; Van Belle S; Van Vlierberghe H; de Hemptinne B; Dierckx RA
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1374-9. PubMed ID: 12271421
[TBL] [Abstract][Full Text] [Related]
36. [Intervention treatment of hepatocellular carcinoma with 125I-lipiodol plus chemotherapeutic drugs and self body hairs: a report of 56 cases].
Xu C; Wang J; Zheng S
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):42-4. PubMed ID: 11776595
[TBL] [Abstract][Full Text] [Related]
37. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
[TBL] [Abstract][Full Text] [Related]
38. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131].
Werenne X
Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570
[TBL] [Abstract][Full Text] [Related]
39. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
Dumortier J; Chapuis F; Borson O; Davril B; Scoazec JY; Poncet G; Henry L; Boillot O; Mion F; Berger F; Partensky C; Paliard P; Valette PJ
Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002
[TBL] [Abstract][Full Text] [Related]
40. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
